Do headaches get the attention they deserve?

Migraine is an important cause of disability worldwide, but what priority does it have in neurology residency training programs? And do residents and research fellows acquire the skills they need to provide the best possible management for patients with headache? David Garciá Azorin, University of Valladolid, Spain, presented the results of a survey that answers these questions on behalf of the Residents and Research Fellow Section of the EAN National Representative at EAN 2020.

Migraine is the second most common neurological disorder (prevalence 13,847/100,000 in 20161) after tension-type headache1 and the second most common cause of all diseases of years lived with disability after low back pain.2

Education in headache disorders is often not obligatory in residency training

Are these high prevalences of migraine and migraine-related disability reflected in education in headache disorders in neurology residency training programs across Europe? Substantial variation has been shown in the choice of obligatory rotations.3

 

Neurology residency training survey on headache education

Dr Garciá Azorin and his colleagues sent an email invitation with two reminders to all their European colleagues asking for participation in an online survey on headache education. Responses were provided by colleagues in 24 countries who reported:

  • mean number of hours of education about headache disorders at medical school of less than 10 hours (80% of responses) and in half these cases the allocated time is 2 hours or less
  • education in headache disorders is not mandatory during residency (57% of responses) though headache disorders were often an option (80% of responses), which in most cases was for 1 month or less

Residents do not feel fully confident in the management and treatment of patients with headache

Participants were also asked about the skills and confidence they acquired during residency:

  • around 80% could use the main preventive medications for headache and could recognize the red flags
  • 70% could take a headache-specific history and 62.5% could use the International Classification of Headache Disorders
  • around 25% could do anesthetic blockade and treat headache in children
  • on a scale of 1–10, mean confidence to diagnose headache was 6 and mean confidence to treat headache was 6

Despite the high prevalence of headache disorders, education in headache is not an obligatory heart of residents’ curriculum in many European countries, said Dr Garciá Azorin, and residents do not feel fully confident in management and treatment headache patients.

 

For the latest updates on sea.progress.im, subscribe to our Telegram Channel https://bit.ly/telePiM

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. GBD 2015 Neurological Disorders Collaborator Group. Lancet Neurol 2017;16:877–97.
  2. GBD 2016 Neurological Disorders Collaborator Group. Lancet Neurol 2019;18:459–80.
  3. Kleineberg NN, et al. Eur J Neurol 2020 Apr 5. doi: 10.1111/ene.14242. Online ahead of print.
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country